Literature DB >> 4069607

Ocular chrysiasis.

S A McCormick, A G DiBartolomeo, V K Raju, I R Schwab.   

Abstract

Thirty-four patients who had received over 1 gram of gold compounds for rheumatoid arthritis were examined for ocular chrysiasis. Ninety-seven percent of the patients receiving continuous chrysotherapy at the time of their ocular examination exhibited corneal chrysiasis. With few exceptions, corneal gold deposits were limited to the posterior one-half of the corneal thickness. Deposits tended to concentrate inferiorly and to spare the superior and peripheral cornea. Duration of chrysotherapy correlated positively with the clinically graded density of deposits. In this series, 55% (16/29) of these patients receiving gold therapy for three years or more had lenticular chrysiasis, although this has previously been considered rare. Our data suggest that gold is deposited in the cornea and lens from the anterior chamber aqueous fluid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069607     DOI: 10.1016/s0161-6420(85)33846-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  A 54-year-old man with bilateral symmetrical circular corneal opacities.

Authors:  Colm McAlinden; Christopher P R Williams
Journal:  Digit J Ophthalmol       Date:  2020-06-21

Review 2.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 3.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

4.  Crystalline-like keratopathy after intravenous immunoglobulin therapy with incomplete kawasaki disease: case report and literature review.

Authors:  Elif Erdem; Emine Kocabas; Hande Taylan Sekeroglu; Ozlem Ozgür; Meltem Yagmur; T Reha Ersoz
Journal:  Case Rep Ophthalmol Med       Date:  2013-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.